FRMD1
geneOn this page
Also known as FLJ00181DKFZp434O0117FLJ40260FLJ22615bA164L23.1
Summary
FRMD1 (FERM domain containing 1, HGNC:21240) is a protein-coding gene on chromosome 6q27, encoding FERM domain-containing protein 1 (Q8N878).
Predicted to be involved in positive regulation of hippo signaling. Predicted to be located in cytoskeleton. Predicted to be active in cytoplasmic side of apical plasma membrane.
Source: NCBI Gene 79981 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 150 total
- MANE Select transcript:
NM_024919
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21240 |
| Approved symbol | FRMD1 |
| Name | FERM domain containing 1 |
| Location | 6q27 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ00181, DKFZp434O0117, FLJ40260, FLJ22615, bA164L23.1 |
| Ensembl gene | ENSG00000153303 |
| Ensembl biotype | protein_coding |
| Entrez | 79981 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 6 protein_coding, 3 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000283309, ENST00000336070, ENST00000358587, ENST00000432403, ENST00000440994, ENST00000468647, ENST00000506415, ENST00000509157, ENST00000511714, ENST00000644440, ENST00000646385
RefSeq mRNA: 3 — MANE Select: NM_024919
NM_001122841, NM_001394681, NM_024919
CCDS: CCDS47518, CCDS5306, CCDS94036
Canonical transcript exons
ENST00000283309 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001355851 | 168078882 | 168079212 |
| ENSE00002027656 | 168053095 | 168057339 |
| ENSE00003504311 | 168062894 | 168062959 |
| ENSE00003539387 | 168067367 | 168067446 |
| ENSE00003546222 | 168064871 | 168065057 |
| ENSE00003553321 | 168059124 | 168059188 |
| ENSE00003638162 | 168075245 | 168075335 |
| ENSE00003662641 | 168060761 | 168061057 |
| ENSE00003681330 | 168063601 | 168063756 |
| ENSE00003682212 | 168061807 | 168061981 |
| ENSE00003788885 | 168066755 | 168066831 |
Expression profiles
Bgee: expression breadth ubiquitous, 115 present calls, max score 88.17.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3054 / max 107.6608, expressed in 65 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 76730 | 0.1147 | 30 |
| 76732 | 0.0652 | 17 |
| 76731 | 0.0551 | 3 |
| 76733 | 0.0321 | 11 |
| 76725 | 0.0221 | 3 |
| 76727 | 0.0083 | 3 |
| 76726 | 0.0077 | 3 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 88.17 | gold quality |
| sural nerve | UBERON:0015488 | 87.74 | gold quality |
| body of stomach | UBERON:0001161 | 78.51 | gold quality |
| tibial nerve | UBERON:0001323 | 77.88 | gold quality |
| transverse colon | UBERON:0001157 | 77.39 | gold quality |
| rectum | UBERON:0001052 | 76.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.48 | gold quality |
| stomach | UBERON:0000945 | 74.23 | gold quality |
| right testis | UBERON:0004534 | 73.05 | gold quality |
| left testis | UBERON:0004533 | 72.97 | gold quality |
| fundus of stomach | UBERON:0001160 | 72.80 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 72.23 | silver quality |
| renal glomerulus | UBERON:0000074 | 72.11 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 70.78 | gold quality |
| testis | UBERON:0000473 | 70.37 | gold quality |
| nephron tubule | UBERON:0001231 | 70.07 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 69.82 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 69.70 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 69.50 | gold quality |
| colonic mucosa | UBERON:0000317 | 69.43 | gold quality |
| nipple | UBERON:0002030 | 69.43 | gold quality |
| superior surface of tongue | UBERON:0007371 | 69.39 | gold quality |
| cardia of stomach | UBERON:0001162 | 69.33 | gold quality |
| vena cava | UBERON:0004087 | 69.25 | gold quality |
| saphenous vein | UBERON:0007318 | 69.12 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 68.94 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 68.85 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 68.82 | gold quality |
| pericardium | UBERON:0002407 | 68.78 | gold quality |
| body of tongue | UBERON:0011876 | 68.76 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.49 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting FRMD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-4656 | 98.79 | 66.22 | 1306 |
| HSA-MIR-2467-3P | 98.65 | 67.18 | 1969 |
| HSA-MIR-4726-3P | 98.49 | 63.89 | 1385 |
| HSA-MIR-4722-5P | 98.46 | 66.34 | 1611 |
| HSA-MIR-197-3P | 98.09 | 69.23 | 1004 |
| HSA-MIR-4468 | 98.01 | 66.85 | 1187 |
| HSA-MIR-943 | 97.81 | 64.42 | 694 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-3127-5P | 97.52 | 65.24 | 786 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
| HSA-MIR-125A-3P | 97.04 | 66.92 | 902 |
| HSA-MIR-1343-5P | 96.48 | 66.06 | 1506 |
| HSA-MIR-6726-5P | 95.97 | 63.72 | 841 |
| HSA-MIR-4300 | 95.85 | 64.56 | 1003 |
| HSA-MIR-5591-5P | 95.85 | 64.76 | 1002 |
| HSA-MIR-6805-5P | 95.79 | 64.86 | 670 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | FRMD1 | ENSDARG00000078741 |
| danio_rerio | si:ch73-205h11.1 | ENSDARG00000096757 |
| drosophila_melanogaster | ex | FBGN0004583 |
| caenorhabditis_elegans | WBGENE00001493 |
Protein
Protein identifiers
FERM domain-containing protein 1 — Q8N878 (reviewed: Q8N878)
All UniProt accessions (7): Q8N878, A0A2R8Y4L9, A0A2R8Y579, A0A2R8Y6M2, A0A2R8Y7X7, D6RB43, H0Y9A3
UniProt curated annotations — full annotation on UniProt →
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N878-1 | 1 | yes |
| Q8N878-2 | 2 |
RefSeq proteins (3): NP_001116313, NP_001381610, NP_079195* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000299 | FERM_domain | Domain |
| IPR014352 | FERM/acyl-CoA-bd_prot_sf | Homologous_superfamily |
| IPR018979 | FERM_N | Domain |
| IPR018980 | FERM_PH-like_C | Domain |
| IPR019748 | FERM_central | Domain |
| IPR019749 | Band_41_domain | Domain |
| IPR029071 | Ubiquitin-like_domsf | Homologous_superfamily |
| IPR035963 | FERM_2 | Homologous_superfamily |
| IPR047145 | FRMD6-like | Family |
Pfam: PF00373, PF09379
UniProt features (10 total): region of interest 3, compositionally biased region 2, sequence variant 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N878-F1 | 66.72 | 0.37 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 39 (showing top):
GOBP_HIPPO_SIGNALING, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, chr6q27, GOCC_CELL_CELL_JUNCTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOCC_ANCHORING_JUNCTION, MARTENS_TRETINOIN_RESPONSE_UP, GOBP_REGULATION_OF_HIPPO_SIGNALING, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ATF2_UP.V1_UP, PTEN_DN.V2_DN, IL15_UP.V1_DN, KRAS.600.LUNG.BREAST_UP.V1_UP, KRAS.LUNG_UP.V1_UP
GO Biological Process (1): positive regulation of hippo signaling (GO:0035332)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytoplasmic side of apical plasma membrane (GO:0098592), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| hippo signaling | 1 |
| regulation of hippo signaling | 1 |
| positive regulation of intracellular signal transduction | 1 |
| binding | 1 |
| cytoplasmic side of plasma membrane | 1 |
| apical plasma membrane | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
718 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FRMD1 | KIF25 | Q9UIL4 | 627 |
| FRMD1 | WWC3 | Q9ULE0 | 589 |
| FRMD1 | DYNLT2 | Q8IZS6 | 574 |
| FRMD1 | DACT2 | Q5SW24 | 566 |
| FRMD1 | WDR27 | A2RRH5 | 547 |
| FRMD1 | WWC2 | Q6AWC2 | 525 |
| FRMD1 | KRTAP2-1 | Q9BYU5 | 506 |
| FRMD1 | SMOC2 | Q9H3U7 | 501 |
| FRMD1 | PHF10 | Q8WUB8 | 479 |
| FRMD1 | MAST3 | O60307 | 475 |
| FRMD1 | KRTAP2-2 | Q9BYT5 | 468 |
| FRMD1 | CMTM8 | Q8IZV2 | 466 |
| FRMD1 | KASH5 | Q8N6L0 | 460 |
| FRMD1 | SPRR4 | Q96PI1 | 445 |
| FRMD1 | BKGD | Q9H0W9 | 442 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RAB2A | FRMD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FRMD1 | A2ML1 | psi-mi:“MI:0914”(association) | 0.530 |
| PIN4 | FRMD1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| ORF4 | DNM1L | psi-mi:“MI:0914”(association) | 0.350 |
| FRMD1 | TRIM37 | psi-mi:“MI:0914”(association) | 0.350 |
| FRMD1 | RAB2A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (91): MUC7 (Affinity Capture-MS), BPIFA2 (Affinity Capture-MS), MUC5B (Affinity Capture-MS), MPO (Affinity Capture-MS), IGHA2 (Affinity Capture-MS), SCEL (Affinity Capture-MS), SPRR3 (Affinity Capture-MS), PIGR (Affinity Capture-MS), SKAP2 (Affinity Capture-MS), CRNN (Affinity Capture-MS), AMY1C (Affinity Capture-MS), GBP6 (Affinity Capture-MS), DSG3 (Affinity Capture-MS), CST2 (Affinity Capture-MS), A2ML1 (Affinity Capture-MS)
ESM2 similar proteins: A2AKB4, A2APT9, O54824, P49796, Q0V8R5, Q14005, Q32LQ1, Q3B7M3, Q3TYG6, Q494U1, Q4FZU8, Q4V7B1, Q5BJM5, Q5JV73, Q5RA50, Q5SYB0, Q5T7N3, Q68FE6, Q6P1H6, Q6P9J5, Q6PCP7, Q6PG95, Q6ZPF3, Q6ZUX3, Q7TNY7, Q7TP65, Q80TI1, Q80UZ0, Q80XI1, Q80YE4, Q86V42, Q86XL3, Q8BLK9, Q8C886, Q8IVF5, Q8K124, Q8K3I4, Q8K451, Q8N5H7, Q8N878
Diamond homologs: Q8C0V9, Q8N878, Q8VII0, Q96NE9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
150 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 119 |
| Likely benign | 17 |
| Benign | 7 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2337 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:168057340:C:CA | acceptor_loss | 1.0000 |
| 6:168057340:C:CC | acceptor_gain | 1.0000 |
| 6:168061056:CT:C | acceptor_gain | 1.0000 |
| 6:168061815:T:TA | donor_gain | 1.0000 |
| 6:168061818:T:TA | donor_gain | 1.0000 |
| 6:168061819:C:CA | donor_gain | 1.0000 |
| 6:168061831:G:C | donor_gain | 1.0000 |
| 6:168063529:AG:A | donor_gain | 1.0000 |
| 6:168063530:G:C | donor_gain | 1.0000 |
| 6:168063550:C:A | donor_gain | 1.0000 |
| 6:168063588:C:CA | donor_gain | 1.0000 |
| 6:168063632:T:TA | donor_gain | 1.0000 |
| 6:168063650:T:TA | donor_gain | 1.0000 |
| 6:168063753:TGAT:T | acceptor_gain | 1.0000 |
| 6:168063755:AT:A | acceptor_gain | 1.0000 |
| 6:168063755:ATC:A | acceptor_loss | 1.0000 |
| 6:168063757:C:CC | acceptor_gain | 1.0000 |
| 6:168064870:CCCA:C | donor_gain | 1.0000 |
| 6:168064906:T:TA | donor_gain | 1.0000 |
| 6:168064907:C:A | donor_gain | 1.0000 |
| 6:168066750:GTTA:G | donor_loss | 1.0000 |
| 6:168066752:TACCT:T | donor_loss | 1.0000 |
| 6:168066753:ACC:A | donor_loss | 1.0000 |
| 6:168066756:TTATG:T | donor_gain | 1.0000 |
| 6:168066758:ATGAC:A | donor_gain | 1.0000 |
| 6:168066830:CC:C | acceptor_gain | 1.0000 |
| 6:168066831:CC:C | acceptor_gain | 1.0000 |
| 6:168066931:G:C | donor_gain | 1.0000 |
| 6:168067360:CACTT:C | donor_loss | 1.0000 |
| 6:168067361:ACTTA:A | donor_loss | 1.0000 |
AlphaMissense
3605 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:168063658:G:C | F249L | 0.990 |
| 6:168063658:G:T | F249L | 0.990 |
| 6:168063660:A:G | F249L | 0.990 |
| 6:168065035:A:C | Y162D | 0.990 |
| 6:168064898:G:C | F207L | 0.987 |
| 6:168064898:G:T | F207L | 0.987 |
| 6:168064900:A:G | F207L | 0.987 |
| 6:168065018:C:A | K167N | 0.985 |
| 6:168065018:C:G | K167N | 0.985 |
| 6:168067410:A:T | L114H | 0.983 |
| 6:168067430:A:C | F107L | 0.980 |
| 6:168067430:A:T | F107L | 0.980 |
| 6:168067432:A:G | F107L | 0.980 |
| 6:168067387:A:G | W122R | 0.979 |
| 6:168067387:A:T | W122R | 0.979 |
| 6:168063648:C:G | A253P | 0.978 |
| 6:168075265:A:G | F95S | 0.978 |
| 6:168064881:A:G | F213S | 0.977 |
| 6:168075264:A:C | F95L | 0.977 |
| 6:168075264:A:T | F95L | 0.977 |
| 6:168075266:A:G | F95L | 0.977 |
| 6:168075259:A:T | L97H | 0.975 |
| 6:168075313:A:T | L79H | 0.975 |
| 6:168067385:C:A | W122C | 0.974 |
| 6:168067385:C:G | W122C | 0.974 |
| 6:168075313:A:G | L79P | 0.974 |
| 6:168075322:C:T | G76D | 0.974 |
| 6:168064878:G:T | P214Q | 0.973 |
| 6:168063659:A:G | F249S | 0.972 |
| 6:168064962:G:T | A186D | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000002206 (6:168091180 T>C), RS1000025484 (6:168069580 C>A), RS1000095756 (6:168074801 G>C), RS1000137048 (6:168093731 A>G), RS1000295096 (6:168059944 A>C,G), RS1000346801 (6:168060536 C>G,T), RS1000534435 (6:168077139 A>C), RS1000550879 (6:168074992 T>C,G), RS1000571142 (6:168066169 C>A,T), RS1000577975 (6:168071105 G>C), RS1000627461 (6:168061383 G>A,C), RS1000737496 (6:168092743 T>C), RS1000802021 (6:168091774 C>T), RS1000810380 (6:168066669 A>C,G), RS1000817767 (6:168082353 C>T)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:614065
GenCC curated gene-disease
Mondo (1): distal myopathy with posterior leg and anterior hand involvement (MONDO:0013550)
Orphanet (1): FLNC-related handgrip and calf weakness-distal myopathy (Orphanet:63273)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001535_4 | Immune reponse to smallpox (secreted IL-2) | 3.000000e-07 |
| GCST004068_14 | Venous thromboembolism adjusted for sickle cell variant rs77121243-T | 6.000000e-06 |
| GCST009391_547 | Metabolite levels | 6.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004645 | response to vaccine |
| EFO:0004873 | cytokine measurement |
| EFO:0010496 | hippuric acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol F | increases methylation | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| ferrous chloride | increases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, affects cotreatment, affects response to substance | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Lipopolysaccharides | affects response to substance, affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): distal myopathy with posterior leg and anterior hand involvement, venous thromboembolism